Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options
Peptic ulcer is a chronic disease affecting up to 10% of the world's population. The formation
of peptic ulcers depends on the presence of gastric juice pH and the decrease in mucosal …
of peptic ulcers depends on the presence of gastric juice pH and the decrease in mucosal …
Barrett esophagus and risk of esophageal cancer: a clinical review
SJ Spechler - Jama, 2013 - jamanetwork.com
Importance Barrett esophagus, a complication of gastroesophageal reflux disease (GERD),
predisposes patients to esophageal adenocarcinoma, a tumor that has increased in …
predisposes patients to esophageal adenocarcinoma, a tumor that has increased in …
[HTML][HTML] Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial
Background & Aims For decades, proton pump inhibitors (PPIs) have been the mainstay of
treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan …
treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan …
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis
Background and aims Acid-suppressive medications, particularly proton pump inhibitors
(PPIs), may decrease the risk of oesophageal adenocarcinoma (OAC) in patients with …
(PPIs), may decrease the risk of oesophageal adenocarcinoma (OAC) in patients with …
Control of gastric acid secretion in health and disease
ML Schubert, DA Peura - Gastroenterology, 2008 - Elsevier
Recent milestones in the understanding of gastric acid secretion and treatment of acid-
peptic disorders include the (1) discovery of histamine H2-receptors and development of …
peptic disorders include the (1) discovery of histamine H2-receptors and development of …
Cholecystokinin and gastrin receptors
M Dufresne, C Seva, D Fourmy - Physiological reviews, 2006 - journals.physiology.org
Cholecystokinin and gastrin receptors (CCK1R and CCK2R) are G protein-coupled
receptors that have been the subject of intensive research in the last 10 years with …
receptors that have been the subject of intensive research in the last 10 years with …
Gastrin, cholecystokinin, signaling, and biological activities in cellular processes
Q Zeng, L Ou, W Wang, DY Guo - Frontiers in endocrinology, 2020 - frontiersin.org
The structurally-related peptides, gastrin and cholecystokinin (CCK), were originally
discovered as humoral stimulants of gastric acid secretion and pancreatic enzyme release …
discovered as humoral stimulants of gastric acid secretion and pancreatic enzyme release …
Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?
Over recent decades we have witnessed a shift in the anatomical distribution of gastric
cancer (GC), which increasingly originates from the proximal stomach near the junction with …
cancer (GC), which increasingly originates from the proximal stomach near the junction with …
Reflux, Barrett's oesophagus and adenocarcinoma: burning questions
CP Wild, LJ Hardie - Nature Reviews Cancer, 2003 - nature.com
The incidence of oesophageal adenocarcinoma is increasing rapidly in Western
populations. Gastro-oesophageal reflux disease is a strong risk factor for both this tumour …
populations. Gastro-oesophageal reflux disease is a strong risk factor for both this tumour …
Proton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a systematic review and meta-analysis
Q Hu, TT Sun, J Hong, JY Fang, H **ong, SJ Meltzer - PloS one, 2017 - journals.plos.org
Objectives Proton pump inhibitors (PPIs) have been used for treatment of Barrett's
esophagus (BE) for many years. However, the connection between PPIs and esophageal …
esophagus (BE) for many years. However, the connection between PPIs and esophageal …